Aptargroup (ATR) 80.23 $ATR AptarGroup Hits a 52-Week

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Aptargroup (ATR) 80.23 $ATR

AptarGroup Hits a 52-Week High: What's Driving the Stock?
Zacks Equity Research - Zacks Investment Research - Tue Jul 12, 7:22AM CDT
AptarGroup (ATR) has hit a 52-week high on expected benefits from product diversification, extensive geographic reach and product introductions.
ATR: 80.23 (-0.18), MTW: 5.59 (-0.05), ASTE: 57.77 (-0.80), ALG: 65.41 (-0.20)

AptarGroup Releases Corporate Sustainability Report
BusinessWire - Fri May 13, 10:33AM CDT
AptarGroup, Inc. (NYSE: ATR), a global dispensing solutions provider, today released its 2015 Corporate Sustainability Report. The report highlights sustainability activities that took place across the Company's global network in 2015. This is AptarGroup's second report prepared using the Global Reporting Initiative (GRI) framework and contains standard disclosures from the GRI G4 (Core) Sustainability Reporting Guidelines. AptarGroup obtained limited external assurance for absolute energy metrics, carbon emissions and renewable energy purchases.
ATR: 80.23 (-0.18)

Owens-Illinois (OI) Up on Q1 Earnings Beat; '16 View Raised
Zacks Equity Research - Zacks Investment Research - Tue May 03, 6:27AM CDT
Owens-Illinois, Inc.'s (OI) first-quarter 2016 adjusted earnings beat the Zacks Consensus Estimate by 20%.
OI: 17.94 (+0.06), SEE: 48.37 (+0.58), ATR: 80.23 (-0.18), BMS: 52.62 (+0.66)

AptarGroup (ATR) Shares Dip as Q1 Earnings, Revenues Miss
Zacks Equity Research - Zacks Investment Research - Mon May 02, 9:11AM CDT
Shares of AptarGroup, Inc.(ATR) have fallen as both Q1 earnings and revenues missed the Zacks Consensus Estimate.
GPK: 13.09 (-0.02), CCK: 51.86 (-0.08), ATR: 80.23 (-0.18), GEF: 39.70 (-0.16)

AptarGroup Grows Revenue and Earnings Per Share on a Comparable Basis
BusinessWire - Thu Apr 28, 4:00PM CDT
AptarGroup, Inc. (NYSE:ATR) today announced first quarter core sales and earnings per share growth on a comparable basis.
ATR: 80.23 (-0.18)

Sealed Air (SEE) Tops Q1 Earnings, Maintains 2016 Outlook
Zacks Equity Research - Zacks Investment Research - Thu Apr 28, 11:48AM CDT
Sealed Air Corporation's (SEE) Q1 adjusted earnings per share surpassed the Zacks Consensus Estimate.
SEE: 48.37 (+0.58), ATR: 80.23 (-0.18), BMS: 52.62 (+0.66), PKG: 70.98 (+0.34)

Grainger (GWW) Beats on Q1 Earnings & Sales, Cuts View
Zacks Equity Research - Zacks Investment Research - Mon Apr 18, 10:43AM CDT
Grainger's (GWW) first-quarter 2016 earnings and sales beat the Zacks Consensus Estimate.
BGG: 22.44 (-0.11), AVY: 73.18 (+0.22), GWW: 230.57 (+0.13), ATR: 80.23 (-0.18)

Astec to Benefit from Continuous Investment; Risks Remain
Zacks Equity Research - Zacks Investment Research - Fri Apr 15, 1:05PM CDT
Astec (ASTE) will benefit from continuous investment.
BLL: 71.33 (+0.05), AVY: 73.18 (+0.22), ATR: 80.23 (-0.18), ASTE: 57.77 (-0.80)

AptarGroup Declares Quarterly Dividend
BusinessWire - Fri Apr 15, 10:00AM CDT
The Board of Directors of AptarGroup, Inc. (NYSE: ATR) today declared a quarterly cash dividend of $0.30 per share. The payment date is May 18, 2016, to stockholders of record as of April 27, 2016.
ATR: 80.23 (-0.18)

Will Deere's (DE) Growth Drivers Help Overcome Headwinds?
Zacks Equity Research - Zacks Investment Research - Wed Apr 13, 10:30AM CDT
Deere (DE) will benefit from the divestiture of non-core assets and acquisitions.
BGG: 22.44 (-0.11), DE: 82.96 (+0.54), ATR: 80.23 (-0.18), ASTE: 57.77 (-0.80)

Ball Corporation Unveils New Website for Customers' Ease
Zacks Equity Research - Zacks Investment Research - Tue Apr 12, 2:20PM CDT
Ball Corporation (BLL) has launched a new, redesigned website ??? www.ball.com.
CCK: 51.86 (-0.08), BLL: 71.33 (+0.05), AVY: 73.18 (+0.22), ATR: 80.23 (-0.18)

AptarGroup Looks Good on Product Strength: Time to Buy?
Zacks Equity Research - Zacks Investment Research - Wed Apr 06, 1:15PM CDT
On Apr 4, 2016, we issued an updated research report on AptarGroup, Inc. (ATR).
SON: 51.51 (-0.08), BLL: 71.33 (+0.05), ATR: 80.23 (-0.18), BMS: 52.62 (+0.66)

Lindsay (LNN) Plunges on Dismal Q2 Earnings and Sales
Zacks Equity Research - Zacks Investment Research - Fri Apr 01, 9:20AM CDT
Lindsay's (LNN) second-quarter fiscal 2016 earnings missed the Zacks Consensus Estimate.
LNN: 69.21 (-0.24), BGG: 22.44 (-0.11), ATR: 80.23 (-0.18), ASTE: 57.77 (-0.80)

AptarGroup (ATR) at 52-Week High on Strong Prospects
Zacks Equity Research - Zacks Investment Research - Thu Mar 31, 3:25PM CDT
Shares of AptarGroup, Inc. (ATR) scaled a new 52-week high of $79.04 on Mar 30, eventually closing at $78.73.
SON: 51.51 (-0.08), GHM: 20.74 (-0.20), ATR: 80.23 (-0.18), ASTE: 57.77 (-0.80)

Astec Receives $122.5M Pellet Plant Order for Highland Pellets
Zacks Equity Research - Zacks Investment Research - Thu Mar 31, 1:35PM CDT
Astec (ASTE) has won $122.5 million of a pellet plant order for Highland Pellets.
BLL: 71.33 (+0.05), GWW: 230.57 (+0.13), ATR: 80.23 (-0.18), ASTE: 57.77 (-0.80)

Lindsay (LNN) to Report Q2 Earnings: What's in the Cards?
Zacks Equity Research - Zacks Investment Research - Wed Mar 30, 8:50AM CDT
Lindsay (LNN) is slated to report second-quarter fiscal 2016 results on Mar 31.
LNN: 69.21 (-0.24), BGG: 22.44 (-0.11), ATR: 80.23 (-0.18), AOS: 90.46 (-0.50)

Global Aerosol Valve Market Worth USD 1.73 Billion by 2022 - Analysis, Technologies & Forecasts Report 2016-2022 - Key Vendors: AptarGroup, DS Containers, Lindal Group - Research and Markets
BusinessWire - Wed Mar 30, 8:20AM CDT
Research and Markets has announced the addition of the "Aerosol Valve Market Analysis By Product (Continuous, Metered), By Application (Personal Care, Household, Automotive & Industrial, Food, Paints, Medical) And Segment Forecasts To 2022" report to their offering.
ATR: 80.23 (-0.18)

Voxeljet (VJET) Q4 Earnings Preview: Will it Surprise?
Zacks Equity Research - Zacks Investment Research - Mon Mar 28, 10:40AM CDT
Voxeljet AG (VJET) is slated to report fourth-quarter 2015 results on Mar 31, 2016, after the closing bell.
VJET: 4.57 (unch), BRKR: 25.02 (+0.16), BP: 36.56 (-0.35), ATR: 80.23 (-0.18)

Look for Shares of Aptargroup to Potentially Pullback after Yesterday's 1.24% Rise
Comtex SmarTrend(R) - Mon Mar 21, 4:27PM CDT
Aptargroup (NYSE:ATR) traded in a range yesterday that spanned from a low of $76.82 to a high of $77.99. Yesterday, the shares gained 1.2%, which took the trading range above the 3-day high of $77.76 on volume of 79,000 shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
ATR: 80.23 (-0.18)

Manitowoc Announces Right-Sizing Actions to Boost Efficiency
Zacks Equity Research - Zacks Investment Research - Mon Mar 21, 1:50PM CDT
Manitowoc (MTW) has announced actions to further right-size the Crane business.
SON: 51.51 (-0.08), ATR: 80.23 (-0.18), MTW: 5.59 (-0.05), ASTE: 57.77 (-0.80)

Scroll down for more posts ▼

Top 10 Most Recent News Articles

LEGO Mashes Star Wars and Marvel for Fans' Delight

Updated Category News Views 38

A New Chapter in LEGO's Story Well, well, what do we have here? LEGO's throwing down the gauntlet. For the first time, they're asking fans to merge two colossal universes: Star Wars and Marvel. Talk about a brains-and-bricks bonanza! Announced at New York Comic Con with some star power from Kevin Smith, this LEGO Ideas challenge opens doors for fan creativity that might...

Continue Reading
AbbVie's SKYRIZI and RINVOQ Highlight IBD Control Advances

Updated Category News Views 43

A Deeper Look Into AbbVie's Latest Data Let's cut straight to the science, folks. At the recent American College of Gastroenterology 2026 Annual Scientific Meeting, AbbVie pulled the curtain on 22 fresh scientific abstracts that are really shaking things up in the field of inflammatory bowel disease (IBD) treatment. Data from the Phase 3 AFFIRM study shined especially...

Continue Reading
2026 Community Impact Week: Slam Dunk for Community Unity

Updated Category News Views 38

Alright, if you're looking for a story that gives you those warm fuzzy feelings while wrapping you in a big sports hug, here it is. Imagine this: you've got basketball legends, world-class athletes, and a corporate heavyweight, all huddling up to make a community impact that's more than just warm air. Hoops, Hope, and High Fives The NBA Cares x Sands Cares Community...

Continue Reading
Sebela Pharma's Tegoprazan Posts Strong Phase 3 Data

Updated Category News Views 35

Spotlight on Tegoprazan: A New Player on the GERD Field Sometimes, a pharma company turns heads with data that speaks for itself. This time, Sebela Pharmaceuticals is doing just that with Tegoprazan's phase 3 results, shining a light on an area overlooked for too long: non-erosive reflux disease (NERD). Showing promise in its latest trials, Tegoprazan is muscling into the...

Continue Reading
Duolingo Faces Lawsuit Over Alleged Investor Missteps

Updated Category News Views 47

Fasten your seatbelts, folks. We're diving into a legal tussle that could shake things up for Duolingo, Inc. (NASDAQ: DUOL). Investors who plunged into Duolingo shares between May 2, 2025, and February 26, 2026, might be feeling the heat now. They ought to brace for a class-action lawsuit frenzy with fingers pointed at Duolingo for allegedly pulling wool over investors'...

Continue Reading
Celltrion Unveils New Data on Infliximab: ACG 2026 Insight

Updated Category News Views 44

First Impressions: Celltrion's Latest Revelation Alright, let's jump straight into it. Celltrion USA is flaunting its latest findings on ZYMFENTRA® (infliximab-dyyb) for Crohn's disease and ulcerative colitis right at the American College of Gastroenterology's (ACG) grand event in 2026. If you've been watching the healthcare sector, this is significant news. It's got all...

Continue Reading
Pacira BioSciences Faces Shareholder Revolt in M&A Deal

Updated Category News Views 4

A New Storm Brews Over Pacira's Sale to Viatris They say where there's smoke, there's fire, and it looks like Pacira BioSciences, Inc. (NASDAQ: PCRX) is running right into a bonfire thanks to their upcoming sale to Viatris Inc. On the face of it, shareholders are looking at a tidy $36.50 in cash per share, but not everyone's buying the deal as fair. Enter lawman Juan...

Continue Reading

Top 5 Most Recently Viewed Articles

FuboTV Prepares for Q3 2024 Financial Results Release

Updated Category News Views 101

FuboTV to Reveal Q3 2024 Financial Insights FuboTV Inc. (d/b/a Fubo) (NYSE: FUBO), a prominent player in the sports streaming arena, has announced a significant event on the horizon. They will release their third quarter financial results for 2024 early in the market day, a move that provides a valuable update for investors and followers alike. Details about the Financial...

Continue Reading
Coinbase's Gokul Rajaram's Share Sale Highlights Market Trends

Updated Category News Views 262

Gokul Rajaram of Coinbase Sells Shares Recently, Gokul Rajaram, a director at Coinbase Global, Inc. (NASDAQ:COIN), made headlines by selling shares worth $64,536. This transaction took place in September, when he sold 400 shares at a price of $161.34 each. Such moves often attract a lot of attention from those tracking the cryptocurrency market and its developments...

Continue Reading
Robinhood's New Fund Unlocks Private AI Investments for All

Updated Category News Views 200

Robinhood Ventures' Bold Move Into Private AI Investments Robinhood Markets Inc. (NASDAQ: HOOD) is set to revolutionize the investment landscape by giving retail investors access to private startups focused on artificial intelligence (AI). Despite widespread chatter about a potential bubble in the AI sector, the company is moving forward with this innovative approach....

Continue Reading
IRG, PREP, and DWREP Join Forces for Major Site Redevelopment

Updated Category News Views 184

Investment in Future Growth In an exciting development, Industrial Realty Group, LLC (IRG), along with Provider Real Estate Partners (PREP) and DW Real Estate Partners, LLC (DWREP), have embarked on a significant project to redevelop an industrial property in Ohio. The trio has successfully acquired the Hilliard Commerce Center, a sprawling 177,680 square-foot facility...

Continue Reading
Understanding Publicis Groupe’s Recent Share Trading Activity

Updated Category News Views 149

Overview of Share Trading Activities Publicis Groupe recently engaged in notable share trading activities, reflecting its strategic moves in the market. This trading involves shares acquired as part of a pre-approved program by the company's shareholders, aimed at enhancing its capital management. Transaction Details During the latest trading window, Publicis Groupe...

Continue Reading